EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform law.

Contacted: Labor, Dept of (DOL); Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); Executive Office of the President (EOP); Federal Trade Commission (FTC); Food & Drug Administration (FDA); SENATE; Office of Personnel Management (OPM); White House Office; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO)

Health Issues HCR

Regulatory policies related to the health reform law: structure, drug benefits, disclosure. Regulatory implementation of HITECH/accounting of disclosures. Issues regarding making prescription drugs more affordable. Restrictions on specialty tiering.

Contacted: Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Labor, Dept of (DOL); SENATE; Office of Personnel Management (OPM); White House Office; Executive Office of the President (EOP); Food & Drug Administration (FDA); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES

Postal POS

Postal reform proposals and their impact on 6 day mail delivery.

Contacted: SENATE; Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); White House Office; HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Labor, Dept of (DOL); Executive Office of the President (EOP); Congressional Budget Office (CBO); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General Legislative and regulatory issues such as direct negotiation. Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors prompt pay discounts from the definition of average sales prices. Medicare audit and preferred network restrictions. HR 244; HR 793.

Contacted: Executive Office of the President (EOP); SENATE; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Federal Trade Commission (FTC); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA)

Bills named: H.R. 793 (114th), H.R. 244 (114th)

Pharmacy PHA

Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR, specialty pharmacy tiering restrictions. Regulatory implementation of a pathway for the approval of biosimilars. REMs. 340b program reform. policies placing restrictions on pharmacy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse, including Medicare lock-in programs. General issues dealing with regulating pharmacy drug compounding. HR 1600.

Contacted: SENATE; Internal Revenue Service (IRS); White House Office; Executive Office of the President (EOP); Food & Drug Administration (FDA); Federal Trade Commission (FTC); Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); Government Accountability Office (GAO)

Bills named: H.R. 1600 (114th)

Defense DEF

Pharmacy issues related to the annual defense reauthorization (HR 1735,S 1376).

Contacted: Office of Personnel Management (OPM); SENATE; Executive Office of the President (EOP); Federal Trade Commission (FTC); Government Accountability Office (GAO); Internal Revenue Service (IRS); White House Office; Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO)

Bills named: H.R. 1735 (114th)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for the purposes of negotiating with payers.

Contacted: Government Accountability Office (GAO); Office of Personnel Management (OPM); White House Office; Executive Office of the President (EOP); Labor, Dept of (DOL); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); SENATE; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS)